119
Participants
Start Date
December 31, 2002
Primary Completion Date
July 31, 2004
Study Completion Date
September 30, 2004
Semapimod
60 mg IV x 3 days q 6 - 8 weeks
Asher Kornbluth, MD, New York
Long Island Clinical Research Associates, Great Neck
Rochester General Hospital, Rochester
Advanced Gastroenterology Associates, Suwanee
Atlanta Gastroenterology Associates, Atlanta
Gastroenterology Associates, Bristol
Northwestern University, Chicago
University of California, San Francisco, San Francisco
Cliniques Universitaires Saint-Luc, Brussels
Academic Hospital Gasthuisberg, Leuven
Benjamin Franklin University, Berlin
Medizinischen Hochschule-Hannover, Hanover
Universitats Klinikum Heidelberg, Heidelberg
University of Kiel, Kiel
Gastroenterologische Fachpraxis, Minden
Stadtisches Krankenhaus Munchen-Bogenhausen, München
University of Munster, Münster
Rambam Medical Center, Haifa
Hadassah Medical Center, Jerusalem
Shaare Zedek Hospital, Jerusalem
Tel Aviv Sourasky Medical Center, Tel Aviv
Chaim Sheba Medical Center, Tel Litwinsky
Academic Medical Center, Amsterdam
Free University (Vrije Universiteit), Amsterdam
Academisch Ziekenhuis Maastricht, Maastricht
Erasmus Medical Center, Rotterdam
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY